‍

As breakthroughs in cancer treatment continue to accelerate, understanding their impact on healthcare economics is pivotal. In Europe, novel therapies and diagnostics present significant challenges and opportunities for payers and health systems.

‍

Adam Scott, Partner, Mansfield Advisors

‍Abhishek Patel, Senior Associate, Mansfield Advisors

‍Henry Elphick, Chair, Mansfield Advisors

‍Stephane Budel, Co-founder/Partner, DeciBio Consulting

‍Katie Gillette, Senior Project Manager, DeciBio Consulting

‍

Complete the form below to receive the slides from this webinar.

‍